View Older Stories View More Recent Stories
-
Roth Capital Downgrades Rigel Pharmaceuticals (RIGL) to Neutral
-
Roth Capital Starts MoSys, Inc. (MOSY) at Buy
-
Roth Capital Starts Prothena Corp (PRTA) at Buy
-
Overland Storage (OVRL) Affirms Merger Proposal from Tandberg Data
-
Roth Capital Resumes Summer Infant (SUMR) at Neutral
-
Roth Capital Resumes Crown Crafts (CRWS) at Buy
-
Roth Capital Resumes LeapFrog (LF) at Buy
-
Roth Capital Resumes Kid Brands (KID) at Neutral
-
Apricus Bio (APRI) Prices 6M Common Stock Offering
-
Cimatron (CIMT) Secondary Offering Priced at $6.25/Share
-
Roth Capital Downgrades Acquity Group (AQ) to Neutral
-
Cimatron (CIMT) Announces Common Secondary Offering
-
Roth Capital Downgrades Conceptus (CPTS) to Neutral
-
Acadia Pharmaceuticals, (ACAD) Prices 8M Share Offering at $12.50/Sh
-
Notable Analyst Rating Changes 05/14: (WY) (FIO) (MDRX) Upgraded; (CI) (KBH) (AVG) Downgraded
-
Roth Capital Starts Acura Pharmaceuticals (ACUR) at Buy
-
Roth Capital Starts NV5 Holdings (NVEEU) at Buy
-
Roth Capital Downgrades SolarCity (SCTY) to Neutral
-
MoSys (MOSY) Announces Common Stock Offering
-
Roth Capital Downgrades Dendreon (DNDN) to Sell
-
ICU Medical (ICUI) Enterprise Value of $1 Billion Implies $82/Share Price
-
Roth Capital Upgrades U.S. Auto Parts Network (PRTS) to Buy
-
UPDATE: BMO Capital Downgrades Synta Pharma. (SNTA) to Market Perform
-
Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp
-
Notable 52-Week Highs and Lows of the Day 05/03: (AIG) (STX) (GILD) High; (DCTH) (ZAGG) (VCRA) Low
-
Notable Analyst Rating Changes 05/03: (GM) (BZH) (RDC) Upgraded; (DCTH) (SYY) (LULU) Downgraded
-
Roth Capital Downgrades Delcath Systems (DCTH) to Sell
-
Roth Capital Downgrades ZAGG Incorporated (ZAGG) to Neutral
-
Roth Capital Starts Hudson Technologies (HDSN) at Buy
-
NV5 Holdings (NVEEU) IPO Trades Flat
-
Roth Capital Downgrades Obagi Medical Products (OMPI) to Neutral
-
Coastal Contacts (COA) Announces Common Stock Offering
-
Cimatron Limited (CIMT) Offering of 2.5M Shares Priced at $5.25 for Holders
-
Intellipharmaceutics (IPCI) Commences $.1M Capital Raise Via Direct Offering
-
Notable Analyst Rating Changes 03/15: (FCX) (CPST) (SEE) Upgraded; (DAL) (SCHW) (PGR) Downgraded
-
Roth Capital Starts Response Genetics (RGDX) at Buy
-
Roth Capital Upgrades Capstone Turbine (CPST) to Buy
-
Roth Capital Starts QuickLogic (QUIK) at Buy
-
Roth Capital Starts Redhill Biopharma (RDHL) at Buy
-
Roth Capital Starts TG Therapeutics (TGTX) at Buy
-
Roth Capital Downgrades GSI Group (GSIG) to Neutral
-
Roth Capital Starts Verastem (VSTM) at Buy
-
Roth Capital Downgrades World Wrestling Entertainment (WWE) to Neutral
-
Roth Capital Downgrades Vitacost.com (VITC) to Sell
-
Roth Capital Starts Cytori Therapeutics, Inc. (CYTX) at Buy
-
Wireless Ronin (RNIN) Sinks on $1.56M Offering
-
Roth Capital Resumes Perry Ellis (PERY) at Buy
-
Limoneira (LMNR) Underwriters Exercise Full Overallotment in Equity Offering
-
Roth Capital Upgrades CIBER (CBR) to Buy
-
Roth Capital Upgrades inContact (SAAS) to Buy

